(268 days)
Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device, is intended to provide 50 Hz shear wave speed measurements and estimates of tissue stiffness as well as Ultrasound Attenuation Parameter (UAP) in internal structures of the body.
Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device is intended to provide 100Hz shear wave speed measurements and estimates of tissue stiffness in spleen.
Shear Wave Quantificational Ultrasound Diagnostic System is indicated as a non-invasive aid for the clinical management, diagnosis, and monitoring of adult and pediatric patients with confirmed or suspected liver disease, as part of an overall assessment of the liver. Results in the pediatric population should be interpreted while considering the clinical condition and the overall patient profile.
Shear Wave Quantificational Ultrasound Diagnostic System is intended for general purpose pulse echo ultrasound imaging and Doppler flow analysis in the human body (including abdominal applications) in B, M, CFM, PWD, B/B, 4B, B+M, B+CFM, B+PWD, and B+CFM+PWD modes.
The system must be operated by qualified and appropriately trained medical professionals in a professional healthcare facility environment.
The subject system is a general purpose, software-controlled, diagnostic ultrasound system. It is composed of a complex probe, an imaging probe, a main unit, a power cord, a foot switch, two fuses and a protective earth wire. The complex probe is a convex array probe used for elasticity measurement and ultrasound imaging, and the imaging probe is also a convex array probe used for ultrasound imaging. The system uses transient elastography to measure shear wave speed non-invasively and estimate tissue stiffness as well as Ultrasound Attenuation Parameter (UAP) in internal structures of the body. A mechanical vibrator in the complex probe produces low-frequency shear waves at 50 Hz or 100HZ that travel through the skin and intercostal space into the liver or spleen respectively. The propagation speed of the shear wave is captured by complex probe using ultrasound at 2.5 MHz. Under imaging mode, the system acquires and displays ultrasound images in B, M, CFM, PWD modes. The system uses imaging probe and complex probe with a frequency range of 2.5MHz to 5.0 MHz on abdomen for general purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body. The ultrasonic imaging also helps to find a proper location for the Transient Elastography examination.
There are a total of 6 models in this product, all of which share the same intended use, physical design and principle of technology. The only differences among these models are software functions configuration and availability of imaging probe.
N/A
FDA 510(k) Clearance Letter - K250026
Page 1
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
Doc ID # 04017.08.00
October 1, 2025
Wuxi Hisky Medical Technologies Co., Ltd.
℅ Siming Wang
Consultant
Shenzhen Joyantech Consulting Co., Ltd
1713A, 17th Floor, Block A
Zhongguan Times Square Nanshan District
Shenzhen, Guangdong 518000
China
Re: K250026
Trade/Device Name: Shear Wave Quantificational Ultrasound Diagnostic System (FH9000/FH7000/FH6000/FH5000/FH3000/FH1000)
Regulation Number: 21 CFR 892.1550
Regulation Name: Ultrasonic Pulsed Doppler Imaging System
Regulatory Class: Class II
Product Code: IYN, IYO, ITX
Dated: September 2, 2025
Received: September 2, 2025
Dear Siming Wang:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Page 2
K250026 - Siming Wang Page 2
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-
Page 3
K250026 - Siming Wang Page 3
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
YANNA S. KANG -S
Yanna Kang, Ph.D.
Assistant Director
Mammography and Ultrasound Team
DHT8C: Division of Radiological
Imaging and Radiation Therapy Devices
OHT8: Office of Radiological Health
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
Page 4
Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Submission Number (if known): K250026
Device Name: Shear Wave Quantificational Ultrasound Diagnostic System (FH9000/FH7000/FH6000/FH5000/FH3000/FH1000)
Indications for Use (Describe)
Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device, is intended to provide 50 Hz shear wave speed measurements and estimates of tissue stiffness as well as Ultrasound Attenuation Parameter (UAP) in internal structures of the body.
Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device is intended to provide 100Hz shear wave speed measurements and estimates of tissue stiffness in spleen.
Shear Wave Quantificational Ultrasound Diagnostic System is indicated as a non-invasive aid for the clinical management, diagnosis, and monitoring of adult and pediatric patients with confirmed or suspected liver disease, as part of an overall assessment of the liver. Results in the pediatric population should be interpreted while considering the clinical condition and the overall patient profile.
Shear Wave Quantificational Ultrasound Diagnostic System is intended for general purpose pulse echo ultrasound imaging and Doppler flow analysis in the human body (including abdominal applications) in B, M, CFM, PWD, B/B, 4B, B+M, B+CFM, B+PWD, and B+CFM+PWD modes.
The system must be operated by qualified and appropriately trained medical professionals in a professional healthcare facility environment.
Type of Use (Select one or both, as applicable)
☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Page 5
510(k) Summary
K250026
Date of Preparation: 2025/10/01
1. Submission sponsor
Name: Wuxi Hisky Medical Technologies Co., Ltd.
Address: Room B401, 530 Plaza, University Science Park, Taihu International Science & Technology Park, Wuxi, Jiangsu, 214135, China
Contact person: Jinhua Shao
Title: General Manager
E-mail: shaojinhua@hiskymedical.com
Tel: +86051085387867
2. Submission correspondent
Name: Shenzhen Joyantech Consulting Co.,Ltd.
Address: 1713A, 17th Floor, Block A, Zhongguan Times Square Nanshan District, Guangdong Province, China.
Contact person: Siming Wang
E-mail: siming.wang@cefda.com
Tel: +8675686069197
3. Identification of Proposed Device
| Trade Name | Shear Wave Quantificational Ultrasound Diagnostic System |
|---|---|
| Common Name | Diagnostic Ultrasound System and Accessories |
| Model Name | FH9000/ FH7000/FH6000/FH5000/FH3000/ FH1000 |
| Submission type | Traditional 510(k) submission |
| Classification name | 1) Ultrasonic Pulsed Echo Imaging System2) Diagnostic Ultrasound Transducer3) Ultrasonic Pulsed Doppler Imaging System |
| Classification | Class II |
| Regulation number | 21 CFR 892.1560 & 21 CFR 892.1570 & 21 CFR 892.1550 |
| Product Code | IYO, ITX , IYN |
| Review Pane | Radiology |
Page 6
4. Identification of Predicate Device
Primary predicate
| Trade Name | Shear Wave Quantificational Ultrasound Diagnostic System |
|---|---|
| Common Name | Diagnostic Ultrasound System and Accessories |
| Model Name | FT9000, FT100, Mini800 |
| 510(k) number | K200136 |
| Classification name | 1) Ultrasonic Pulsed Echo Imaging System2) Diagnostic Ultrasound Transducer3) Ultrasonic Pulsed Doppler Imaging System |
| Classification | Class II |
| Regulation number | 21 CFR 892.1560 & 21 CFR 892.1570 & 21 CFR 892.1550 |
| Product Code | IYO, ITX , IYN |
| Review Pane | Radiology |
| Manufacture | Wuxi Hisky Medical Technologies Co., Ltd. |
Reference device
| Trade name | FibroScan® device (Models: 502 Touch, 530 Compact, 430 Mini+, 230, and 630) |
|---|---|
| Common Name | Diagnostic Ultrasound System and Accessories |
| Model Name | 502 Touch, 530 Compact, 430 Mini+, 230, and 630 |
| 510(k) number | K223902 |
| Classification name | 1) Ultrasonic Pulsed Echo Imaging System2) Diagnostic Ultrasound Transducer |
| Classification | Class II |
| Regulation number | 21 CFR 892.1560 & 21 CFR 892.1570 |
| Product Code | IYO, ITX |
| Review Pane | Radiology |
| Manufacture | Echosens |
5. Device Description
The subject system is a general purpose, software-controlled, diagnostic ultrasound system. It is
Page 7
composed of a complex probe, an imaging probe, a main unit, a power cord, a foot switch, two fuses and a protective earth wire. The complex probe is a convex array probe used for elasticity measurement and ultrasound imaging, and the imaging probe is also a convex array probe used for ultrasound imaging. The system uses transient elastography to measure shear wave speed non-invasively and estimate tissue stiffness as well as Ultrasound Attenuation Parameter (UAP) in internal structures of the body. A mechanical vibrator in the complex probe produces low-frequency shear waves at 50 Hz or 100HZ that travel through the skin and intercostal space into the liver or spleen respectively. The propagation speed of the shear wave is captured by complex probe using ultrasound at 2.5 MHz. Under imaging mode, the system acquires and displays ultrasound images in B, M, CFM, PWD modes. The system uses imaging probe and complex probe with a frequency range of 2.5MHz to 5.0 MHz on abdomen for general purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body. The ultrasonic imaging also helps to find a proper location for the Transient Elastography examination.
There are a total of 6 models in this product, all of which share the same intended use, physical design and principle of technology. The only differences among these models are software functions configuration and availability of imaging probe. The table below shows the differences among these models:
Table 1 Differences among different models
| No. | Model | Complex Probe | Imaging Probe | Quick Query Function | Multiuser Management System | automatic diagnosis function | Data docking support function | Advanced search function | Automatic cleaning function | HTTP & JSON support function | Ordinary compressed storage | Advanced compressed storage |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FH9000 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| 2 | FH7000 | √ | √ | √ | - | √ | √ | √ | √ | √ | √ | √ |
| 3 | FH6000 | √ | √ | √ | √ | - | √ | √ | √ | √ | √ | √ |
| 4 | FH5000 | √ | A | √ | √ | √ | - | √ | √ | - | √ | √ |
| 5 | FH3000 | √ | A | √ | √ | √ | √ | - | √ | √ | - | √ |
| 6 | FH1000 | √ | A | √ | √ | √ | √ | √ | √ | - | √ | √ |
Note:"-"represents "not equipped"，"√" represents "equipped ", "A"represents "optional".
6. Indication for use
Page 8
Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device, is intended to provide 50Hz shear wave speed measurements and estimates of tissue stiffness as well as Ultrasound Attenuation Parameter (UAP) in internal structures of the body.
Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device is intended to provide 100Hz shear wave speed measurements and estimates of tissue stiffness in spleen.
Shear Wave Quantificational Ultrasound Diagnostic System is indicated as a non-invasive aid for the clinical management, diagnosis, and monitoring of adult and pediatric patients with confirmed or suspected liver disease, as part of an overall assessment of the liver. Results in the pediatric population should be interpreted while considering the clinical condition and the overall patient profile.
Shear Wave Quantificational Ultrasound Diagnostic System is intended for general purpose pulse echo ultrasound imaging and Doppler flow analysis in the human body （including abdominal applications） in B, M, CFM, PWD, B/B, 4B, B+M, B+CFM, B+PWD, and B+CFM+PWD modes.
The system must be operated by qualified and appropriately trained medical professionals in a professional healthcare facility environment.
Page 9
7. Substantially Equivalent (SE) Comparison
The following tables show the comparison results between subject device and predicate devices and the differences between the subject device and the predicate and reference devices has been analyzed for risks in the safety and effectiveness of subject device. The comparison results show that the subject device is determined to be Substantially Equivalent (SE) to the predicate device.
Table 2 Comparison of subject device with primary predicate device
| Comparison item | Subject device | Primary predicate device(K200136) | Discussion |
|---|---|---|---|
| Device Model | FH9000, FH7000, FH6000, FH5000, FH3000, FH1000 | FT9000 | / |
| Regulation Number | 21 CFR 892.1560 & 21 CFR 892.1570 & 21 CFR 892.1550 | 21 CFR 892.1550 & 21 CFR 892.1560 & 21 CFR 892.1570 | Same |
| Product Code | IYO, ITX, IYN | IYO, ITX, IYN | Same |
| Indications for use | Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device, is intended to provide 50Hz shear wave speed measurements and estimates of tissue stiffness as well as Ultrasound Attenuation Parameter (UAP) in internal structures of the body.Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device is intended to provide 100Hz | Shear Wave Quantificational Ultrasound Diagnostic System (Models: FT9000, FT100 and Mini800), Transient Elastography based device, is intended to provide 50Hz shear wave speed measurements and estimates of tissue stiffness as well as Ultrasound Attenuation Parameter (UAP) in internal structures of the body.Shear Wave Quantificational Ultrasound Diagnostic System (Models: FT9000, FT100 and Mini800), is indicated for noninvasive | SimilarBoth the subject device and the primary predicate device are used for:a.Liver stiffness measurement;b.Attenuation Parameter measurementc.General purpose pulse echo ultrasound imaging and Doppler flow analysis. |
Page 10
| Indications for use (continued) | shear wave speed measurements and estimates of tissue stiffness in spleen.Shear Wave Quantificational Ultrasound Diagnostic System is indicated as a non-invasive aid for the clinical management, diagnosis, and monitoring of adult and pediatric patients with confirmed or suspected liver disease, as part of an overall assessment of the liver. Results in the pediatric population should be interpreted while considering the clinical condition and the overall patient profile.Shear Wave Quantificational Ultrasound Diagnostic System is intended for general purpose pulse echo ultrasound imaging and Doppler flow analysis in the human body （including abdominal applications） in B, M, CFM, PWD, B/B, 4B, B+M, B+CFM, B+PWD, and B+CFM+PWD modes.The system must be operated by qualified and appropriately trained medical professionals in a professional healthcare facility environment | measurement in the liver of 50 Hz shear wave speed and estimates of stiffness as well as Ultrasound Attenuation Parameter (UAP).The shear wave speed and stiffness, and UAP may be used as an aid to diagnosis and monitoring of patients with liver disease, as part of an overall assessment of the liver.Shear Wave Quantificational Ultrasound Diagnostic System (Models: FT9000), is intended for general purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body. It can be used in the following applications:Abdominal, including location of the liver. | The difference is that the subject device has an additional indication for use for spleen stiffness measurement, which is included in the indication for use of the reference device. Therefore, the difference doesn't raise new risks in regard to safety and effectiveness of the subject device. |
Page 11
| Patient population | adults, and pediatric patients. | adults | DifferentAlthough the patient population of the subject device is different from the primary predicate, this technical characteristic is same as the reference device. The performance applied to pediatric patients is verified, this difference does not raise any questions related to safety and effectiveness. |
| TE Probe Nominal Frequency | FH-C1 complex probe:2.5MHz | FT-2.5D9 fibrosis scanning probe:2.5MHz | Same |
| Type | Multiple array element transducer | Single element transducer | DifferentAs multiple array element transducer of the complex probe FH-C1 can electronically focus the sound beam at different depths and angles by controlling the timing and amplitude of the electrical signals sent to each element. So the complex probe offers better image quality, resolution and penetration depth compared to single-element transducers.Therefore, the difference doesn't raise different questions of safety and |
Page 12
| effectiveness than the predicate device | |||
|---|---|---|---|
| Function | a.Stiffness measurement of liver and spleen;b.UAP measurement of liver;c.General purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body | a.Stiffness measurement of liverb.UAP measurement of liver | SimilarThe subject device and the primary predicate device have the same functions of liver stiffness and UAP measurement.But the subject device has the following additional functions:1.spleen stiffness measurement;This function is same with the reference device. And the function is verified.Therefore, the difference doesn't raise new risks in regard to safety and effectiveness of the subject device. |
| Mode | Vibration-Controlled Transient Elastography mode | A mode and M mode | SimilarAlthough the mode of the subject device and the predicate device is different, they can execute the same Transient Elastography measurement function.Therefore, the difference doesn't raise different questions of safety and effectiveness than the predicate device |
Page 13
| Source of Mechanical Vibration | External electromechanical Vibrator | External electromechanical Vibrator | Same |
|---|---|---|---|
| Ultrasound Source | Piezoelectric ultrasound source | Piezoelectric ultrasound source | Same |
| Measurement depth | 15-85mm | 15-85mm | Same |
| Ultrasound imaging Probe Nominal Frequency | FH-C1 complex probe:2.5MHzFH-C2 imaging probe :3.5MHz | FT-3.5R65 imaging probe:3.5MHz | SimilarAlthough the probe frequency of the subject device is different from that of the predicate device, they can execute the same ultrasound imaging function.Therefore, the difference doesn't raise different questions of safety and effectiveness than the predicate device |
| Mode | B, M, CFM, PWD, B/B,4B,B+M，B+CFM, B+PWD，B+CFM+PWD | B, B/B, B/D, CFM and PWD mode | SimilarThe subject device has broader range of application of M mode, which is a widely used mode in ultrasound device.Therefore, the difference doesn't raise different questions of safety and |
Page 14
| effectiveness than the predicate device. | |||
|---|---|---|---|
| Type | Multiple array element transducer | Multiple array element transducer | Same |
| Function | General purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body | General purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body | Same |
| Ultrasound Source | Piezoelectric ultrasound source | Piezoelectric ultrasound source | Same |
| TE display | Liver Shear wave speed (0.8-5.2m/s)Spleen Shear wave speed (0.8-5.8 m/s)Liver Stiffness (2.0-80 kPa)Spleen Stiffness(2kPa -100kPa)Interquartile range (IQR) and IQR/median ratio | Liver Shear wave speed (0.8-5.2 m/s)Liver Stiffness (2.0-80 kPa)Interquartile range (IQR) and IQR/median ratio | SimilarBoth the subject device and the primary predicate device have the same TE display in terms of liver stiffness, except that the subject device has additional display for spleen stiffness, which is equivalent to the function of the reference device's TE probe.Therefore, the difference doesn't raise new risks in regard to safety and |
Page 15
| effectiveness than the predicate device. | |||
|---|---|---|---|
| TE Bias | Liver stiffness (-5.2%) – (4.2%) | (-4.7%) - (2.4%) | SimilarBoth the subject device and the primary predicate device have similar performance parameters in terms of liver stiffness and the difference is slight and doesn't raise different questions of safety and effectiveness than the predicate device.And the subject device has additional function of spleen stiffness, which is equivalent to the function of the reference device's TE probe.Therefore, the difference doesn't raise new risks in regard to safety and effectiveness of the subject device. |
| Spleen stiffness (-5.2%) – (4.2%) | / | ||
| TE Precision | Liver stiffness (0.0%) – (0.67%) | (0.0%) – (1.6%) | |
| Spleen stiffness (0.0%) – (0.67%) | / | ||
| UAP display | UAP (90-450 dB/m)Interquartile range (IQR) and IQR/median ratio | UAP (90-450 dB/m)Interquartile range (IQR) and IQR/median ratio | Same |
| UAP Bias | (-1.8%) - (0.3%) | (-3.3%) – (2.0%) | Similar |
Page 16
| UAP Precision | (0.1%) – (1.0%) | (0.2%) – (1.5%) | Similar |
|---|
Page 17
Table 3 Comparison of subject device with Reference device
| Comparison item | Subject device | Reference device(K223902) | Discussion |
|---|---|---|---|
| Device Model | FH9000, FH7000, FH6000, FH5000, FH3000, FH1000 | 630 | / |
| Regulation Number | 21 CFR 892.1560 & 21 CFR 892.1570 & 21 CFR 892.1550 | 21 CFR 892.1560 & 21 CFR 892.1570 | SimilarThe reference device doesn't have pulsed Doppler imaging function, so 21 CFR 892.1550 is inapplicable. |
| Product Code | IYO, ITX, IYN | IYO, ITX | SimilarThe reference device doesn't have pulsed Doppler imaging function, so IYN is inapplicable. |
| Indications for use | Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device, is intended to provide 50Hz shear wave speed measurements and estimates of tissue stiffness as well as Ultrasound Attenuation Parameter (UAP) in internal structures of the body.Shear Wave Quantificational Ultrasound Diagnostic System, Transient Elastography based device is intended to provide 100Hz shear wave speed measurements and estimates | The FibroScan® device (Models: 502 Touch, 530 Compact, 430 Mini+, 230, and 630) is intended to measure liver stiffness (E) using Vibration Controlled Transient Elastography™ (VCTE™) at 50 Hz shear wave frequency and liver ultrasound attenuation coefficient (CAP™)* at 3.5 MHz. FibroScan® 630 Expert is also intended to measure spleen stiffness using VCTE™ at 100 Hz shear wave frequency. | SimilarBoth the subject device and the reference device are used for:a. Measurement of stiffness and Ultrasound Attenuation Parameter of liverb. Measurement of stiffness of spleenThe difference is that the subject device has an additional indication for use for general purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body, which is included in the |
Page 18
| Indications for use (continued) | of tissue stiffness in spleen.Shear Wave Quantificational Ultrasound Diagnostic System is indicated as a non-invasive aid for the clinical management, diagnosis, and monitoring of adult and pediatric patients with confirmed or suspected liver disease, as part of an overall assessment of the liver. Results in the pediatric population should be interpreted while considering the clinical condition and the overall patient profile.Shear Wave Quantificational Ultrasound Diagnostic System is intended for general purpose pulse echo ultrasound imaging and Doppler flow analysis in the human body （including abdominal applications） in B, M, CFM, PWD, B/B, 4B, B+M, B+CFM, B+PWD, and B+CFM+PWD modes.The system must be operated by qualified and appropriately trained medical professionals in a professional healthcare facility environment. | FibroScan liver stiffness measurements (LSM) by VCTE™ may aid the physician in determining the likelihood of cirrhosis and may be used, taken in context with other clinical and laboratory data, as an aid in the assessment of liver fibrosis.FibroScan CAP™ measurements may be used, taken in context with other clinical and laboratory data, as an aid in the assessment of hepatic steatosis.FibroScan® is indicated as a non-invasive aid for the clinical management, diagnosis, and monitoring of adult and pediatric patients with confirmed or suspected liver disease, as part of an overall assessment of the liver. Results in the pediatric population should be interpreted while considering the clinical condition and the overall patient profile.The FibroScan® device is intended for use by healthcare professionals in hospitals, clinics or any facility where healthcare is provided.* CAP™ refers to ultrasound attenuation coefficient (originally defined as | indication for use of the primary predicate device.Therefore, the difference doesn't raise new risks in regard to safety and effectiveness of the subject device. |
Page 19
| Controlled Attenuation Parameter). CAP™ on S+ probe is only available with SmartExam capability. | |||
|---|---|---|---|
| Patient population | adults, and pediatric patients. | adults, and pediatric patients. | Same |
| TE Probe Nominal Frequency | FH-C1 complex Probe: (2.5MHz) | M+probe :3.5 MHzXL+ probe:2.5 MHzS+ probe :5 MHz | SimilarFH-C1 applies to both adult and pediatric patients, however, S+and M+ probe apply to pediatric patients and XL+probe applies to adult patients, which indicates that the probe of subject device has a broader range of application.Therefore, the difference doesn't raise different questions of safety and effectiveness than the reference device. |
| Type | Multiple array element transducer | Single element transducer | DifferentAs multiple array element transducer of the complex probe FH-C1 can electronically focus the sound beam at different depths and angles by controlling the timing and amplitude of the electrical signals sent to each element. So the complex probe offers better image quality, resolution and penetration depth compared to single-element transducers. |
Page 20
| Therefore, the difference doesn't raise different questions of safety and effectiveness than the reference device | |||
|---|---|---|---|
| Function | a.Stiffness measurement of liver and spleen;b.UAP measurement of liver;c. General purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body | a.Stiffness measurement of liver and spleenb.CAP measurement of liver | SimilarThe subject device and the reference device have the same functions of liver stiffness and Ultrasound Attenuation Parameter measurement.But the subject device has the following additional functions:General purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body.This additional function is equivalent to the imaging function of the primary predicate device's ultrasound imaging probe.Therefore, the difference doesn't raise new risks in regard to safety and effectiveness of the subject device. |
| Mode | Vibration-Controlled Transient Elastography mode | A-mode / M-mode Transient Elastography/ Shear Wave / (CAP™) | SimilarAlthough the probe mode of the subject device and the reference device is different, they can execute the same Transient Elastography measurement |
Page 21
| function. Therefore, the difference doesn't raise different questions of safety and effectiveness than the reference device | |||
|---|---|---|---|
| Source of Mechanical Vibration | External electromechanical Vibrator | External electromechanical Vibrator | Same |
| Ultrasound Source | Piezoelectric ultrasound source | Piezoelectric ultrasound source | Same |
| Measurement depth | 15-85mm | S1 exam: 15-40 mmS2 exam: 20-50 mmM exam: 25-65 mmXL exam: 35-75 mm | Similar |
| Ultrasound imaging Probe Nominal Frequency | FH-C2 imaging probe :3.5MHzFH-C1 complex Probe :2.5MHz | ES-C5-2R60S-3 B-Mode ultrasound localization probe: 3.5 MHz | SimilarAlthough the probe frequency of the subject device is different from that of the reference device, they can execute the same ultrasound imaging function.Therefore, the difference doesn't raise different questions of safety and effectiveness than the reference device |
| Mode | B, M,CFM, PWD, B/B，4B，B+M，B+CFM, B+PWD，B+CFM+PWDNote:CFM equates C and PWD equates D | B | Similar:The subject device has broader range of application of M, CFM, PWD mode, which are wildly used mode in ultrasound device.Therefore, the addition of M, |
Page 22
| CFM, PWD mode doesn't raise different questions of safety and effectiveness than the reference device | |||
|---|---|---|---|
| Type | Multiple array element transducer | Multiple array element transducer | Same |
| Function | a.locating of liver and spleenb.General purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body | locating of liver and spleen | SimilarBoth the subject device and the reference device have the same function in locating, except that the subject device has additional function of general purpose pulse echo ultrasound imaging and Doppler flow analysis of the human body, which is equivalent to the function of the primary predicate device's ultrasound imaging probe.Therefore, the difference doesn't raise new risks in regard to safety and effectiveness of the subject device. |
| Ultrasound Source | Piezoelectric ultrasound source | Piezoelectric ultrasound source | Same |
| TE display | Liver Shear wave speed (0.8-5.2m/s)Spleen Shear wave speed (0.8-5.8 m/s)Liver Stiffness (2.0-80 kPa)Spleen Stiffness(2kPa -100kPa)Interquartile range (IQR) and IQR/median | Liver Shear wave speed (0.8-5.0 m/s)Spleen Shear wave speed (1.4-5.8 m/s)Liver Stiffness (2.0-75 kPa)Spleen Stiffness(6kPa -100kPa)Interquartile range (IQR) and IQR/median | Similar |
Page 23
| ratio | ratio | ||
|---|---|---|---|
| TE measurement depth | 15-85mm | S1 exam: 15-40 mmS2 exam: 20-50 mmM exam: 25-65 mmXL exam: 35-75 mm | Similar |
| TE Bias | Liver (-5.2%) – (4.2%) | (-10%) – (-38%) | Similar |
| Spleen (-5.2%) – (4.2%) | (-31%) – (-44%) | Similar | |
| TE Precision | Liver (0.0%) – (0.67%) | ≤3% | Similar |
| Spleen (0.0%) – (0.67%) | ≤1% | Similar | |
| Attenuation display | UAP (90-450 dB/m)Interquartile range (IQR) and IQR/median ratio | CAP (100-400 dB/m)CAP median and interquartile range (IQR) | SimilarThe UAP measurement range of the subject device is larger than that of the reference device. And they have different way of statistic, which doesn't raise different questions of safety and effectiveness than the |
Page 24
| reference device. | |||
|---|---|---|---|
| UAP Bias | (-1.8%) - (0.3%) | (1.0%) – (12.4%) | Similar |
| UAP Precision | (0.1%) – (1.0%) | (0.2%) – (6.9%) | Similar |
8. Non-Clinical Test Conclusion
Non-clinical tests were conducted to verify that the proposed device met all design specifications. The test results demonstrated that the proposed device complies with the following standards and regulations:
1) Biocompatibility
- ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
- ISO 10993-5:2009 Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity
- ISO 10993-10: 2021 Biological evaluation of medical devices – Part 10: Tests for skin sensitization
- ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Test for irritation
2) Reprocessing
- FDA Guidance for industry and Food and Drug Administration Staff Reprocessing medical devices in healthcare setting: Validation Methods and Labeling
- 17664-2:2021: Processing of health care products — Information to be provided by the medical device manufacturer for the processing of medical devices —Part 2:Non-critical medical devices
3) EMC
- IEC 606601-1-2:2014/AMD1:2020 Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests
Page 25
- IEC TR 60601-4-2:2024 Medical electrical equipment - Part 4-2: Guidance and interpretation – Electromagnetic immunity: performance of medical electrical equipment and medical electrical systems
4) Electrical Safety and essential performance
- IEC 60601-1 :2005+A1:2012+A2:2020 Medical electrical equipment Part 1: General requirements for basic safety and essential performance
- IEC 60601-2-37:2015 Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment
- IEC 62359:2017 Ultrasonics - Field characterization - Test methods for the determination of thermal and mechanical indices related to medical diagnostic ultrasonic fields
5) Ultrasound Performance
Following the requirements of FDA ultrasound guidance: Marketing Clearance of Diagnostic Ultrasound Systems and Transducers Guidance for Industry and Food and Drug Administration Staff :2023, bench performances testing were conducted to assure the subject devices' safety and effectiveness:
- Vibration-Controlled Triggered Transient Elastography (TE) and Ultrasound Attenuation Parameter (UAP) measurement accuracy testing including TE detection range, bias, precision; UAP detection range, bias, precision.
- Ultrasound image performance testing including Examination depth, spatial resolution, Geometric Accuracy, detection depth, dead zone, slice thickness, measuring error of circumference and area, time display error, Doppler accuracy and detection depth.
6) Software function
- IEC 62304-2015 Medical device software Software life cycle processes
- General Principles of Software Validation Final Guidance for Industry and FDA Staff: 2002
- Content of Premarket Submissions for Device Software Functions Guidance for Industry and Food and Drug Administration Staff: 2023
7) Cybersecurity
- Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions Guidance for Industry and Food and Drug Administration Staff: 2023
9. Clinical investigation
Page 26
Not applicable
10. Conclusion
In summary, the above information demonstrates that Shear Wave Quantificational Ultrasound Diagnostic System is substantially equivalent to its primary predicate devices and the differences raise no risks in regard to safety and effectiveness of the proposed device.
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.